Editorial
November 25, 2024
Editorial

Comments for: REAL RE-IMPORTS

REAL RE-IMPORTS
The Food and Drug Administration is right to be concerned about the sharp rise in the number of counterfeit drugs being sold in the United States, but the federal government should not confuse the increase in these drugs with the reimportation of lower cost prescriptions. Read More

      You may also like